sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×Ô¾õÐÔ¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Ó

ǰÑÔ

ÈËÀàȱѪÐÔÐÄÔಡ°üÀ¨ÐĽÊÍ´ºÍÐ£ËÀ£¬²¢Çһᱬ·¢Ðļ¡ÏËά»¯ºÍÐÄË¥¡£µ¼ÖÂÐļ¡È±ÑªµÄ×î³£¼ûÔµ¹ÊÔ­ÓÉÊÇÖ¸¹Ú×´¶¯ÂöÖàÑùÓ²»¯»ù´¡ÉÏ£¬¹Ú×´¶¯Âö¾·ÂλòÛÕ±Õµ¼ÖÂÐļ¡È±ÑªÈ±Ñõ»ò»µËÀ£¬¼´¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ(coronary atherosclerotic heart disease)£¬¼ò³Æ¹ÚÐIJ¡¡£Ëü²»µ«ÔÚÅ¹ú¼Ò³£¼û£¬ÔÚÎÒ¹úÒ²³ÊÖðÄêÔöÌíÇ÷ÊÆ£¬½üÄêÀ´³ÉΪÎÒ¹úéæÃüÂÊǰÁ½Î»µÄ¼²²¡Ö®Ò»¡£Õë¶Ô¹ÚÐIJ¡µÄÒ©ÎïÆÀ¼Û£¬Ò»Ö±Ã»ÓкÜÀû±ãÊÊÓõ͝ÎïÄ£×Ó£¬Ö÷ÒªÓÉÓÚ±£´æÒ»Ð©Ç·ºÃ½â¾öµÄÄÑÌâ¡£Ê×ÏÈ£¬ÊÖÊõÓÕ·¢ÀàµÄÄ£×Ó£¬ÊÖÒÕÄѶȴó£¬ÌØÊâÔÚС¶¯ÎïÉϲÙ×÷µÄÒ»ÖÂÐÔÇ·ºÃ¿ØÖÆ£¬¶ø´ó¶¯Îï¹ØÓÚÒ©ÎïÆÀ¼Û²»ÊǺܱ㵱£¬Ð¡¶¯Îïͬʱ»¹±£´æÐĵç¼à¿ØµÈרҵÒÇÆ÷µÄÏÞÖÆ¡£ÁíÍ⣬ÈËÀàÐÄѪ¹ÜÏµÍ³ÌØµãÒÔ¼°ÔÚijЩÇéÐÎÒòËØ£¨ÈçÓ¦¼¤£©Ï·¢²¡µÄÌØµã£¬ÔÚ³£ÓõÄС¶¯ÎïÄ£×ÓÉ϶¼ºÜÄÑÄ£Ä⣬ÏÖÓÐÄ£×ÓºÍÈËÀ༲²¡µÄÏÖÕæÏàÐβî±ðºÜ´ó¡£¾¡¿ÉÄÜÄ£ÄâÈËÀ༲²¡µÄ²¡ÒòºÍ²¡Àí»úÖÆ£¬ÎªÑ°ÕÒȱѪÐÔÐÄÔಡµÄ·ÀÖβ½·¥ÌṩºÜºÃµÄÑо¿Æ½Ì¨£¬ÊÇÕâÀàÄ£×ÓÑо¿µÄÉú³¤Æ«Ïò¡£

¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Óͨ³£ÓÃÁ½ÀàÒªÁì¾ÙÐÐÖÆ×÷¡£µÚÒ»£¬Í¨¹ýÛÕ±Õ»òÏÁÕ­¹Ú×´¶¯ÂöѪ¹ÜÀ´ÊµÏÖÐļ¡È±Ñª£¬ÏÖÔÚ´ó´ó¶¼ÐĹ£¶¯ÎïÄ£×Ó¶¼ÊǽÓÄÉÕâÒ»ÀàÒªÁì¡£µÚ¶þ£¬ÓÕµ¼Ä£×Ó¶¯Îﱬ·¢ÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬´Ó¶øÐγɹÚ×´¶¯ÂöÏÁÕ­¡£¿ÉÊÇ£¬´¿´âÓÕ·¢ÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×ÓºÜÄÑÏ£Íû³öÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬ÕâÊÇÓÉÓÚ¶¯ÎïµÄ¶¯ÂöÖàÑùÓ²»¯²¡±äÖ÷Òª±¬·¢ÔÚ×Ô¶¯ÂöºÍ½üÐĶ˵ĴóѪ¹Ü£¬¹Ú×´¶¯ÂöºÜÄÑ·ºÆð²¡±ä£¨Í¨³£ÐèÒªºÜ³¤µÄÓÕ·¢Ê±¼ä£© £»¼´±ãÄ£×Ó¶¯ÎïµÄ¹Ú×´¶¯Âö·ºÆð¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬Ò²ºÜÉÙ·ºÆðѪ¹ÜÏÁÕ­¡¢ÛÕ±ÕµÈÒýÆðµÄÐļ¡È±ÑªÈ±Ñõ»ò»µËÀµÄÖ¢×´±¬·¢¡£È»¶ø£¬Ëæ×ÅÐÂÊÖÒÕºÍж¯ÎïÄ£×ӵĿª·¢£¬Ò»Ð©»ùÒòÐÞÊλòȱÏݶ¯ÎïÄ£×ÓÔòÄܹ»±¬·¢×ãÒÔÒýÆðÐĹ£±¬·¢µÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬ÈçWHHL¼ÒÍÃÐĹ£Ä£×Ó¡¢Srbl/ApoEË«»ùÒòÇóýСÊóµÈ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎWHHL¼ÒÍÃ

¡¾ÔìÄ £»úÖÆ¡¿£º

 Ð£ËÀÐͶɱßÍÃ(myocardial infarction-prone WHHL rabbits, WHHLMI)ÊÇÔÚÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòWHHL¼ÒÍõĻù´¡ÉÏͨ¹ýÒ»Ö±È˹¤ÌôѡѪ½¬µ¨¹Ì´¼Ë®Æ½½Ï¸ß¡¢¹ÚÂöÖàÑùÓ²»¯²¡±äÑÏÖØ¡¢²¡±ä×é³ÉÖ÷ÒªÓоÞÊÉϸ°ûºÍÅÝĭϸ°ûµÄ×ÓÅ®ÖÐÌôÑ¡²¢·±Óý¶ø³É¡£Òò´Ë£¬WHHLMI¼ÒÍñÈWHHL¼ÒÍõĹÚÂöÔÚÏà¶Ô½Ï¶ÌµÄʱÆÚ¸üÈÝÒ×Ï£Íû³öÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬×îÖÕµ¼Ö¹ÚÂöÏÁÕ­ºÍÐ£ËÀµÄ±¬·¢¡£WHHLMIƷϵ¼ÒÍÃÔÚ2ÔÂÁä×îÏÈÓйÚ×´¶¯ÂöÖàÑùÓ²»¯±¬·¢£¬ÔÚ30ÔÂÁäÐ£ËÀ·ºÆðÂʿɴï97%¡£¶øWHHLMI¼ÒÍõĹÚ×´¶¯ÂöÖàÑùÓ²»¯²¡±ä×é³ÉÒ²ÓëWHHL¼ÒÍòî±ð£¬ WHHLMI¼ÒÍùÚ×´¶¯Âö²¡±äÖ÷ÒªÓÉÅÝĭϸ°ûºÍÑ×ϸ°û×é³É£¬±ÈWRHLMI¼ÒÍÃÖ÷ÒªÓÉÏËάÒòËØ×é³ÉµÄ²¡±ä»»¼Ó²»ÎȹÌ£¬´Ó¶ø¸üÒ×Ôì¹ÊÒ⼡¹£ËÀµÄ±¬·¢¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ͨË×ËÇÁÏËÇι¾Í¿É·ºÆð¸ßµ¨¹Ì´¼ÑªÖ¢£¬2ÔÂÁä¼´¿É·ºÆð¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬10ÔÂÁäºÍ20ÔÂÁä¹Ú×´¶¯ÂöÏÁÕ­±¬·¢ÂÊ»®·ÖΪ70£¥ºÍ90%£¨Í¼5-5)¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

 

¡¾ÔìÄ£ÌØµã¡¿£º

ͨ¹ýÔÚÐĹ£ÇãÏòWHHL¼ÒÍÃÉ϶àÄêɸѡºÍÅàÓý£¬ÓëWHHL¼ÒÍõĹÚ×´¶¯ÂöÏËά²¡±äÓÐËù²î±ð¡£WHHLMI¼ÒÍõĹÚ×´¶¯Âö°ß¿éÓëÈËÀàÒ×Ëð°ß¿é(vulnerable plaque)ºÜÊÇÏàËÆ£¬µä·¶µÄ²¡±äÊÇÓɱ¡ÏËάñÁýÕÖÒ»¸ö´óµÄÖ¬ºË×é³É£¬ÆäÖаüÀ¨¸Æ»¯µãºÍ´ó×Ú¾ÞÊÉϸ°û¡£±ðµÄ£¬Æä°ß¿é²¡Àí½á¹¹»¹°üÀ¨£º°ß¿éÄÚ³öѪ¡¢¸Æ»¯½á½Ú¡¢ÄÚÆ¤²ã°þÍѺÍÏËάÐÔ²¡±ä¡£WHHLMI¼ÒÍÃÀÛ»ýÐĹ£±¬·¢ÂÊÔÚ30ÔÂÁäʱµÖ´ï97%£¬¶øWHHLMI¼ÒÍõÄÐĹ£90£¥ÒÔÉÏÊÇÓɹÚ×´¶¯ÂöÏÁÕ­ÒýÆðµÄ¡£ÁôÉñ¹£±¬·¢Ê±£¬Í¨¹ýECG ÄÜÊӲ쵽WHHLMI¼ÒÍÃÓëÈËÀàÏàËÆµÄST¶Î̧¸ßÕ÷Ï󣬿ÉÊǵ䷶ECG¸Ä±äºÍÐĹ£±¬·¢²¢²»ÍêȫһÖ¡£ËäÈ»WHHLMI¼ÒÍÃÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±äÄܹ»ÒýÆð¹ÚÂöÏÁÕ­ºÍÐĹ£±¬·¢£¬¿ÉÊǵ䷶µÄ°ß¿éÆÆËéÔÚÕâÖÖ¶¯ÎïÄ£×ÓÉÏÈÔÈ»²»Ò×ÊӲ쵽£¬¿ÉÄÜÓÉÓÚWHHLMI¼ÒÍÃȱ·¦µ¼ÖÂÒ×Ëð°ß¿éÆÆËéµÄÆäËûÒòËØ£¬ÈçÇéÐΡ¢ÐÄÀíѹÁ¦¡¢¸ßѪѹµÈ¡£

¡¾Ä£×ÓȪԴ¡¿£º

WHHLMI¼ÒÍÃÔÚÈÕ±¾Éñ»§´óѧ´óѧԺҽѧÑо¿¿ÆÁ¥ÊôʵÑ鶯ÎïÉèÊ©(http://www.med.kobe~u.ac.jp/iea)±£ÖÖ¡¢·±Óý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

 WHHLMI¼ÒÍÃÏÕЩÄܹ»ºÜºÃµØÄ£ÄâÈËÀàÐĹ£µÄ±¬·¢£¬ÊÇÑо¿¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±äÐγɡ¢Ðļ¡È±Ñª¡¢ÐĹ£µÄÓÐÁ¦¹¤¾ß£¬Ò²ÎªÐÂÖÎÁÆÊֶκÍÒ©ÎïÑо¿ÌṩÁ˸üΪ¿¿½üÓÚÈËÀàµÄ¶¯ÎïÄ£×Ó¡£°ß¿éÆÆËéºÍ¼±ÐÔ¹Ú×´¶¯Âö×ÛºÏÕ÷Ò²¿ÉÄÜͨ¹ý±ðµÄ¸ÉÔ¤ÒòËØµÄ½éÈëÔڸö¯ÎïÄ£×ÓÉÏʵÏÖ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅ¿¡Ò壬ÍõÕýÖÒ£¬´÷ºìÑÞ£¬µÈ£®´óÊóÐ£ËÀÄ£×ÓÖÆ×÷ÒªÁì̽ÌÖ£®Çൺ´óѧҽѧԺѧ±¨£¬2013,49(2):121-123

2.¹ùˆÅ£¬ºÂ࣬Àî·å½Ü£¬µÈ£®BeagleÈ®ÓëÔÓÖÖÈ®¼±ÐÔÐ£ËÀÄ£×ӵĽÏÁ¿£®ÖйúÖÐÒ©ÔÓÖ¾£¬2013,28 (12):2001-2004

3.Cozen AE, Moriwaki H, Kremen M, el al.Macrophagetargeted overexpression of urokinase causes acceleratedatherosclerosis,coronary artery occlusions, and premature death. Circulation, 2004,09 (17):2129-2135

4.Cullen P,Baella R,Bellosla S,el al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vase Biol, 2003, 23 (4):535-542

5.Fernandez-Hernando C,Ackah E, Yu J,el al. Loss of Aktl leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab,2007, 6 (6):446-457

6.Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis,aortic aneurysm formation, and ischernic heart disease in apolipoprotein E/endolhelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104 (4):448-454

7.Nakata S, Tsutsui M, Shimokawa H,et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 2008, 117 (17):2211- 2223

8.Shiomi M,Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe., Atherosclerosis, 2009, 207 (1):1-7

9.Trigalli B, Rayburn H, Viiials M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A, 1999,96 (16):9322-9327

10.Zhang S,Picard MH, Vasile E,et al. Diel-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction,and premature death in scavenger receptor class B lype 1-deficient,hypomorphic apolipoprotein ER61 mice. Circulation, 2005, 111(25): 3457-3464

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Ó
×Ô¾õÐÔ¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Ó

ǰÑÔ

ÈËÀàȱѪÐÔÐÄÔಡ°üÀ¨ÐĽÊÍ´ºÍÐ£ËÀ£¬²¢Çһᱬ·¢Ðļ¡ÏËά»¯ºÍÐÄË¥¡£µ¼ÖÂÐļ¡È±ÑªµÄ×î³£¼ûÔµ¹ÊÔ­ÓÉÊÇÖ¸¹Ú×´¶¯ÂöÖàÑùÓ²»¯»ù´¡ÉÏ£¬¹Ú×´¶¯Âö¾·ÂλòÛÕ±Õµ¼ÖÂÐļ¡È±ÑªÈ±Ñõ»ò»µËÀ£¬¼´¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ(coronary atherosclerotic heart disease)£¬¼ò³Æ¹ÚÐIJ¡¡£Ëü²»µ«ÔÚÅ¹ú¼Ò³£¼û£¬ÔÚÎÒ¹úÒ²³ÊÖðÄêÔöÌíÇ÷ÊÆ£¬½üÄêÀ´³ÉΪÎÒ¹úéæÃüÂÊǰÁ½Î»µÄ¼²²¡Ö®Ò»¡£Õë¶Ô¹ÚÐIJ¡µÄÒ©ÎïÆÀ¼Û£¬Ò»Ö±Ã»ÓкÜÀû±ãÊÊÓõ͝ÎïÄ£×Ó£¬Ö÷ÒªÓÉÓÚ±£´æÒ»Ð©Ç·ºÃ½â¾öµÄÄÑÌâ¡£Ê×ÏÈ£¬ÊÖÊõÓÕ·¢ÀàµÄÄ£×Ó£¬ÊÖÒÕÄѶȴó£¬ÌØÊâÔÚС¶¯ÎïÉϲÙ×÷µÄÒ»ÖÂÐÔÇ·ºÃ¿ØÖÆ£¬¶ø´ó¶¯Îï¹ØÓÚÒ©ÎïÆÀ¼Û²»ÊǺܱ㵱£¬Ð¡¶¯Îïͬʱ»¹±£´æÐĵç¼à¿ØµÈרҵÒÇÆ÷µÄÏÞÖÆ¡£ÁíÍ⣬ÈËÀàÐÄѪ¹ÜÏµÍ³ÌØµãÒÔ¼°ÔÚijЩÇéÐÎÒòËØ£¨ÈçÓ¦¼¤£©Ï·¢²¡µÄÌØµã£¬ÔÚ³£ÓõÄС¶¯ÎïÄ£×ÓÉ϶¼ºÜÄÑÄ£Ä⣬ÏÖÓÐÄ£×ÓºÍÈËÀ༲²¡µÄÏÖÕæÏàÐβî±ðºÜ´ó¡£¾¡¿ÉÄÜÄ£ÄâÈËÀ༲²¡µÄ²¡ÒòºÍ²¡Àí»úÖÆ£¬ÎªÑ°ÕÒȱѪÐÔÐÄÔಡµÄ·ÀÖβ½·¥ÌṩºÜºÃµÄÑо¿Æ½Ì¨£¬ÊÇÕâÀàÄ£×ÓÑо¿µÄÉú³¤Æ«Ïò¡£

¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯ÎïÄ£×Óͨ³£ÓÃÁ½ÀàÒªÁì¾ÙÐÐÖÆ×÷¡£µÚÒ»£¬Í¨¹ýÛÕ±Õ»òÏÁÕ­¹Ú×´¶¯ÂöѪ¹ÜÀ´ÊµÏÖÐļ¡È±Ñª£¬ÏÖÔÚ´ó´ó¶¼ÐĹ£¶¯ÎïÄ£×Ó¶¼ÊǽÓÄÉÕâÒ»ÀàÒªÁì¡£µÚ¶þ£¬ÓÕµ¼Ä£×Ó¶¯Îﱬ·¢ÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬´Ó¶øÐγɹÚ×´¶¯ÂöÏÁÕ­¡£¿ÉÊÇ£¬´¿´âÓÕ·¢ÐÔ¶¯ÂöÖàÑùÓ²»¯¶¯ÎïÄ£×ÓºÜÄÑÏ£Íû³öÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬ÕâÊÇÓÉÓÚ¶¯ÎïµÄ¶¯ÂöÖàÑùÓ²»¯²¡±äÖ÷Òª±¬·¢ÔÚ×Ô¶¯ÂöºÍ½üÐĶ˵ĴóѪ¹Ü£¬¹Ú×´¶¯ÂöºÜÄÑ·ºÆð²¡±ä£¨Í¨³£ÐèÒªºÜ³¤µÄÓÕ·¢Ê±¼ä£© £»¼´±ãÄ£×Ó¶¯ÎïµÄ¹Ú×´¶¯Âö·ºÆð¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬Ò²ºÜÉÙ·ºÆðѪ¹ÜÏÁÕ­¡¢ÛÕ±ÕµÈÒýÆðµÄÐļ¡È±ÑªÈ±Ñõ»ò»µËÀµÄÖ¢×´±¬·¢¡£È»¶ø£¬Ëæ×ÅÐÂÊÖÒÕºÍж¯ÎïÄ£×ӵĿª·¢£¬Ò»Ð©»ùÒòÐÞÊλòȱÏݶ¯ÎïÄ£×ÓÔòÄܹ»±¬·¢×ãÒÔÒýÆðÐĹ£±¬·¢µÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬ÈçWHHL¼ÒÍÃÐĹ£Ä£×Ó¡¢Srbl/ApoEË«»ùÒòÇóýСÊóµÈ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎWHHL¼ÒÍÃ

¡¾ÔìÄ £»úÖÆ¡¿£º

 Ð£ËÀÐͶɱßÍÃ(myocardial infarction-prone WHHL rabbits, WHHLMI)ÊÇÔÚÓйÚ×´¶¯ÂöÖàÑùÓ²»¯ÇãÏòWHHL¼ÒÍõĻù´¡ÉÏͨ¹ýÒ»Ö±È˹¤ÌôѡѪ½¬µ¨¹Ì´¼Ë®Æ½½Ï¸ß¡¢¹ÚÂöÖàÑùÓ²»¯²¡±äÑÏÖØ¡¢²¡±ä×é³ÉÖ÷ÒªÓоÞÊÉϸ°ûºÍÅÝĭϸ°ûµÄ×ÓÅ®ÖÐÌôÑ¡²¢·±Óý¶ø³É¡£Òò´Ë£¬WHHLMI¼ÒÍñÈWHHL¼ÒÍõĹÚÂöÔÚÏà¶Ô½Ï¶ÌµÄʱÆÚ¸üÈÝÒ×Ï£Íû³öÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±ä£¬×îÖÕµ¼Ö¹ÚÂöÏÁÕ­ºÍÐ£ËÀµÄ±¬·¢¡£WHHLMIƷϵ¼ÒÍÃÔÚ2ÔÂÁä×îÏÈÓйÚ×´¶¯ÂöÖàÑùÓ²»¯±¬·¢£¬ÔÚ30ÔÂÁäÐ£ËÀ·ºÆðÂʿɴï97%¡£¶øWHHLMI¼ÒÍõĹÚ×´¶¯ÂöÖàÑùÓ²»¯²¡±ä×é³ÉÒ²ÓëWHHL¼ÒÍòî±ð£¬ WHHLMI¼ÒÍùÚ×´¶¯Âö²¡±äÖ÷ÒªÓÉÅÝĭϸ°ûºÍÑ×ϸ°û×é³É£¬±ÈWRHLMI¼ÒÍÃÖ÷ÒªÓÉÏËάÒòËØ×é³ÉµÄ²¡±ä»»¼Ó²»ÎȹÌ£¬´Ó¶ø¸üÒ×Ôì¹ÊÒ⼡¹£ËÀµÄ±¬·¢¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ͨË×ËÇÁÏËÇι¾Í¿É·ºÆð¸ßµ¨¹Ì´¼ÑªÖ¢£¬2ÔÂÁä¼´¿É·ºÆð¹Ú×´¶¯ÂöÖàÑùÓ²»¯£¬10ÔÂÁäºÍ20ÔÂÁä¹Ú×´¶¯ÂöÏÁÕ­±¬·¢ÂÊ»®·ÖΪ70£¥ºÍ90%£¨Í¼5-5)¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

 

¡¾ÔìÄ£ÌØµã¡¿£º

ͨ¹ýÔÚÐĹ£ÇãÏòWHHL¼ÒÍÃÉ϶àÄêɸѡºÍÅàÓý£¬ÓëWHHL¼ÒÍõĹÚ×´¶¯ÂöÏËά²¡±äÓÐËù²î±ð¡£WHHLMI¼ÒÍõĹÚ×´¶¯Âö°ß¿éÓëÈËÀàÒ×Ëð°ß¿é(vulnerable plaque)ºÜÊÇÏàËÆ£¬µä·¶µÄ²¡±äÊÇÓɱ¡ÏËάñÁýÕÖÒ»¸ö´óµÄÖ¬ºË×é³É£¬ÆäÖаüÀ¨¸Æ»¯µãºÍ´ó×Ú¾ÞÊÉϸ°û¡£±ðµÄ£¬Æä°ß¿é²¡Àí½á¹¹»¹°üÀ¨£º°ß¿éÄÚ³öѪ¡¢¸Æ»¯½á½Ú¡¢ÄÚÆ¤²ã°þÍѺÍÏËάÐÔ²¡±ä¡£WHHLMI¼ÒÍÃÀÛ»ýÐĹ£±¬·¢ÂÊÔÚ30ÔÂÁäʱµÖ´ï97%£¬¶øWHHLMI¼ÒÍõÄÐĹ£90£¥ÒÔÉÏÊÇÓɹÚ×´¶¯ÂöÏÁÕ­ÒýÆðµÄ¡£ÁôÉñ¹£±¬·¢Ê±£¬Í¨¹ýECG ÄÜÊӲ쵽WHHLMI¼ÒÍÃÓëÈËÀàÏàËÆµÄST¶Î̧¸ßÕ÷Ï󣬿ÉÊǵ䷶ECG¸Ä±äºÍÐĹ£±¬·¢²¢²»ÍêȫһÖ¡£ËäÈ»WHHLMI¼ÒÍÃÑÏÖØµÄ¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±äÄܹ»ÒýÆð¹ÚÂöÏÁÕ­ºÍÐĹ£±¬·¢£¬¿ÉÊǵ䷶µÄ°ß¿éÆÆËéÔÚÕâÖÖ¶¯ÎïÄ£×ÓÉÏÈÔÈ»²»Ò×ÊӲ쵽£¬¿ÉÄÜÓÉÓÚWHHLMI¼ÒÍÃȱ·¦µ¼ÖÂÒ×Ëð°ß¿éÆÆËéµÄÆäËûÒòËØ£¬ÈçÇéÐΡ¢ÐÄÀíѹÁ¦¡¢¸ßѪѹµÈ¡£

¡¾Ä£×ÓȪԴ¡¿£º

WHHLMI¼ÒÍÃÔÚÈÕ±¾Éñ»§´óѧ´óѧԺҽѧÑо¿¿ÆÁ¥ÊôʵÑ鶯ÎïÉèÊ©(http://www.med.kobe~u.ac.jp/iea)±£ÖÖ¡¢·±Óý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

 WHHLMI¼ÒÍÃÏÕЩÄܹ»ºÜºÃµØÄ£ÄâÈËÀàÐĹ£µÄ±¬·¢£¬ÊÇÑо¿¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¡±äÐγɡ¢Ðļ¡È±Ñª¡¢ÐĹ£µÄÓÐÁ¦¹¤¾ß£¬Ò²ÎªÐÂÖÎÁÆÊֶκÍÒ©ÎïÑо¿ÌṩÁ˸üΪ¿¿½üÓÚÈËÀàµÄ¶¯ÎïÄ£×Ó¡£°ß¿éÆÆËéºÍ¼±ÐÔ¹Ú×´¶¯Âö×ÛºÏÕ÷Ò²¿ÉÄÜͨ¹ý±ðµÄ¸ÉÔ¤ÒòËØµÄ½éÈëÔڸö¯ÎïÄ£×ÓÉÏʵÏÖ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅ¿¡Ò壬ÍõÕýÖÒ£¬´÷ºìÑÞ£¬µÈ£®´óÊóÐ£ËÀÄ£×ÓÖÆ×÷ÒªÁì̽ÌÖ£®Çൺ´óѧҽѧԺѧ±¨£¬2013,49(2):121-123

2.¹ùˆÅ£¬ºÂ࣬Àî·å½Ü£¬µÈ£®BeagleÈ®ÓëÔÓÖÖÈ®¼±ÐÔÐ£ËÀÄ£×ӵĽÏÁ¿£®ÖйúÖÐÒ©ÔÓÖ¾£¬2013,28 (12):2001-2004

3.Cozen AE, Moriwaki H, Kremen M, el al.Macrophagetargeted overexpression of urokinase causes acceleratedatherosclerosis,coronary artery occlusions, and premature death. Circulation, 2004,09 (17):2129-2135

4.Cullen P,Baella R,Bellosla S,el al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vase Biol, 2003, 23 (4):535-542

5.Fernandez-Hernando C,Ackah E, Yu J,el al. Loss of Aktl leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab,2007, 6 (6):446-457

6.Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis,aortic aneurysm formation, and ischernic heart disease in apolipoprotein E/endolhelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104 (4):448-454

7.Nakata S, Tsutsui M, Shimokawa H,et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 2008, 117 (17):2211- 2223

8.Shiomi M,Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe., Atherosclerosis, 2009, 207 (1):1-7

9.Trigalli B, Rayburn H, Viiials M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A, 1999,96 (16):9322-9327

10.Zhang S,Picard MH, Vasile E,et al. Diel-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction,and premature death in scavenger receptor class B lype 1-deficient,hypomorphic apolipoprotein ER61 mice. Circulation, 2005, 111(25): 3457-3464

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿